Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive
$217.6K Funding
5 People
External
Related Topics
cancer therapy,
clinical trial,
pharmacology,
immunotherapy,
drug development
People
Aradhana Kari
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Mitzi Miranda
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor
Angelique Thornton
(CD)
Cancer Center Division
﹒Research Nurse II
Janiel Cragun
Co-Investigator (COI)
Obstetrics and Gynecology
﹒Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
